Gene expression patterns in experimental colitis in IL-10-deficient mice

Inflammatory Bowel Diseases

Volumn 15, Issue 6, 2009, Pages 890-899

  Hansen, Jonathan J ^a   Holt, Lisa ^a   Sartor, R Balfour ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Colitis; DSS; Inflammation; Interleukin 10; Microarray

Indexed keywords

AQUAPORIN 4; CYTOCHROME P450; DEXTRAN SULFATE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 23P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PANCREATIC LIPASE RELATED PROTEIN 2; PREALBUMIN; RIBOSOMAL PROTEIN L33; RIBOSOME PROTEIN; TOLL LIKE RECEPTOR; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELLULAR DISTRIBUTION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPATHOGENESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; AQUAPORIN 4; CECUM; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-10; MICE; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RIBOSOMAL PROTEINS; TH1 CELLS;

EID: 67650225283     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20850     Document Type: Article

References (56)

1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390-407.
2. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445-456.
3. Heimerl S, Moehle C, Zahn A, et al. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochim Biophys Acta. 2006;1762:341-350.
4. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology. 2004;127:26-40.
5. Puleston J, Cooper M, Murch S, et al. A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:109-120.
6. Okahara S, Arimura Y, Yabana T, et al. Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther. 2005;21:1091-1097.
7. Mizoguchi E. Chitinase 34ike-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology. 2006;130:398-411.
8. Mizoguchi E, Xavier RJ, Reinecker HC, et al. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology. 2003;125:148-161.
9. Yamamoto S, Isuzugawa K, Takahashi Y, et al. Intestinal gene expression in TNBS treated mice using genechip and subtractive cDNA analysis: implications for Crohn's disease. Biol Pharm Bull. 2005;28:2046-2053.
10. Iijima H, Takahashi I, Kishi D, et al. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med. 1999;190:607-615.
11. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993;75:274-282.
12. Takahashi I, Kiyono H, Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology. 1997;112:1876-1886.
13. Bouma G, Kaushiva A, Strober W. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology. 2002;123:554-565.
14. Sellon RK, Tonkonogy S, Schultz M, et al. Rosident enteric bacteria are necessary for development of spontaneouss colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224-5231.
15. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
16. Albright CA, Tonkongy SL, Frelinger JA. Adoptive transfer of E. faecalis-pulsed dendritic cells accelerates colitis in IL-10 deficient mice. Gastroenterology. 2003;124:A73 (Abstract).
17. Albright CA, Tonkongy SL, Sartor RB. Antigen presenting cells produce IL-10 in response to IFN gamma. Gastroenterology. 2003,124:A332 (Abstract).
18. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116:1310-1316.
19. Leikauf GD, McDowell SA, Wesselkamper SC, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest. 2002;121:70S-75S.
20. Fuss U, Boirivant M, Lacy B, et al, The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol. 2002; 168:900-908.
21. Liu B, Holt L, Sartor RB. IL-10 production by both antigen presenting cells and CD4+ T lymphocytes maintains mucosal homeostasis. Gastroenterology. 2006;130:A-232 (Abstract).
22. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945-953.
23. Veltkamp C, Tonkonogy SL, De Jong YP, et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. Gastroenterology. 2001;120: 900-913.
24. Clarke CJ, Stokes CR. The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteins. Vet Immunol Immunopathol. 1992;32:125-138.
25. Stimpson SA, Schwab JH. Chronic remittent erosive arthritis induced by bacterial peptidoglycan-polysaccharide structures. Pharmacological methods in the control of inflammation. In: Chang JY, Lewis AJ, eds. New York: Alan R. Liss; 1989. p 381-394.
26. Hansen JJ, Sartor RB. Insights provided by animal models into the pathogenesis and treatment of IBD. IBD Yearbook. Toronto: Remedica Medical Publishing; 2006.
27. Boirivant M, Fuss IJ, Chu A, et al. Oxazolone colitis: a murine model of T helper cep type 2 colitis treatable with antibodies to interleukin 4. J Exp Med. 1998;188:1929-1939.
28. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995; 182: 1281-1290.
29. Albright CA, Tonkongy SL, Sartor RB. Endogenous IL-10 inhibits APC stimulation of T lymphocyte responses to luminal bacteria. Gastroenterology. 2002;122:A270 (Abstract).
30. Davidson NJ, Hudak SA, Lesley RE, et al. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol. 1998; 161:3143-3149.
31. Davidson NJ, Leach MW, Fort MM, et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med. 1996;184:241-251.
32. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428-435.
33. Kang W, Matsushita Y, Grohmann L, et al. Cloning and analysis of the nuclear gene for YmL33, a protein of the large subunit of the mitochondrial ribosome in Saccharomyces cerevisiae. J Bacteriol. 1991;173: 4013-4020.
34. Koc EC, Burkhart W, Blackburn K, et al. The large subunit of the mammalian mitochondrial ribosome. Analysis of the complement of ribosomal proteins present. J Biol Chem. 2001;276;43958-43969.
35. O'Brien TW. Properties of human mitochondrial ribosomes. IUBMB Life. 2003;55:505-513.
36. Matsuzaki T, Tajika Y, Ablimit A, et al. Aquaporins in the digestive system. Med klectron Microsc. 2004;31:71-80.
37. Frigeri A, Gropper MA, Turck CW, et al. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A. 1995;92: 4328-4331.
38. Jung JS, Bhat RV, Preston GM, et al. Molecular characterization of an aquaporin cDNA from brain: candidite osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A. 1994;91:13052-13056.
39. Hasegawa H, Ma T, Skach W, et al. Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues. J Biol Chem. 1994;269:5497-5500.
40. Wang KS, Ma T, Filiz F, et al. Colon water transport in transgenic mice lacking aquaporin-4 water channels. Am J Phystol Gastrointest Liver Physiol. 2000;279.G463-470.
41. Ma T, Yang B, Gillespie A, et al. Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest. 1997;100:957-962.
42. de Baey A, Lanzavecchia A. The role of aquaporins in dendritic cell macropinocytosis. J Exp Med. 2000;191:743-748.
43. Moon C, Rousseau R, Soria JC, et al. Aquaporin expression in human lymphocytes and dendritic cells. Am J Hematol. 2004;75:128-133.
44. Thiagarajah JR, Zhao D, Verkman AS. Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis. Gut. 2007;56: 1529-1535.
45. Kraus TA, Brimnes J, Muong C, et al. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest. 2005; 115:2234-2243.
46. van de Wal Y, Corazza N, Allez M, et al. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology. 2003;124:1420-1431.
47. Hardin JA, Wallace LE, Wong JF, et al. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis. Cell Tissue Res. 2004;318:313-323.
48. Frumento G, Rotondo R, Tonetti M, et al. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002;196: 459-468.
49. Lee GK, Park HJ, Macleod M, et al. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology. 2002; 107:452-460.
50. Munn DH, Shafizadeh E, Attwood JT, et al. Inhibition of T cell proliferation by macrophagetryptophan catabolism. J Exp Med. 1999;189: 1363-1372.
51. Barcelo-Batllori S, Andre M, Servis C, et al. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics. 2002;2:551-560.
52. Gurtner GJ, Newberry RD, Schloemann SR, et al. Inhibition of indoleamine 2,3-dioxygenase augments trinitroberizene sulfbnic acid colitis in mice. Gastroenterology. 2003;125:1762-1773.
53. Mayer L, Eisenhardt D, Salomon P, et al. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology. 1991;100:3-12.
54. Pallone F, Fais S, Capobianchi MR. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol. 1988;74:75-79.
55. Jang MH, Sougawa N, Tanaka T, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. 2006;176:803-810.
56. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3:867-878.